Exporter
Liste modèle des médicaments essentiels
effacer
Trouvé 27 recommandations pour 15 médicaments et 10 équivalents thérapeutiques
Les recommandations supprimées et les demandes rejetées sont affichées. Les cacher.
-
Apixaban Informations générales
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to dabigatran pour Venous thromboembolism Therapeutic equivalent to dabigatran pour Other specified atrial fibrillation -
Cyanocobalamin Informations générales
SectionAntianaemia medicines- .
Indications -
Dabigatran Informations générales
SectionMedicines affecting coagulation- Oral > Solid: 110 mg; 150 mg
-
Dalteparin Informations générales
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to enoxaparin pour Acute ischaemic heart disease Therapeutic equivalent to enoxaparin pour Venous thromboembolism -
Darbepoetin alfa Informations générales
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents pour Anaemia due to chronic disease -
Desmopressin Informations générales
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 4 µg per mL in 1 mL ampoule (acetate)
- Local > Nasal > Spray: 10 µg per dose (acetate)
Indications -
Edoxaban Informations générales
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to dabigatran pour Venous thromboembolism Therapeutic equivalent to dabigatran pour Other specified atrial fibrillation -
Enoxaparin Informations générales
SectionMedicines affecting coagulation- Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule
- Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 120 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule
Indications -
Epoetin alfa Informations générales
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents pour Anaemia due to chronic disease -
Epoetin beta Informations générales
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents pour Anaemia due to chronic disease -
Epoetin theta Informations générales
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents pour Anaemia due to chronic disease -
Erythropoiesis-stimulating agents Informations générales
SectionAntianaemia medicines- Parenteral > General injections > unspecified: 1000 IU per 0.5 mL pre-filled syringe; 2000 IU per 0.5 mL pre-filled syringe; 3000 IU per 0.3 mL pre-filled syringe; 4000 IU per 0.4 mL pre-filled syringe; 5000 IU per 0.5 mL pre-filled syringe; 6000 IU per 0.6 mL pre-filled syringe; 8000 IU per 0.8 mL pre-filled syringe; 10000 IU per 1 mL pre-filled syringe; 20000 IU per 0.5 mL pre-filled syringe; 40000 IU per 1 mL pre-filled syringe
Indications -
Ferrous salt Informations générales
SectionAntianaemia medicines- Oral > Liquid: 25 mg per mL iron (as sulfate)
- Oral > Solid: 60 mg iron
Indications -
Ferrous salt + folic acid Informations générales
SectionAntianaemia medicines- Oral > Solid: 60 mg iron + 2.8 mg
Indications -
Folic acid Informations générales
SectionAntianaemia medicines- Oral > Solid: 1 mg tablet; 5 mg tablet
- Oral > Solid: 400 µg
-
Heparin sodium Informations générales
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 1000 IU per mL in 5 mL ampoule; 20000 IU per mL in 5 mL ampoule; 5000 IU per mL in 5 mL ampoule
-
Hydroxocobalamin Informations générales
SectionAntianaemia medicines- Parenteral > General injections > IM: 1 mg per mL in 1 mL ampoule (as acetate); 1 mg per mL in 1 mL ampoule (as hydrochloride); 1 mg per mL in 1 mL ampoule (as sulfate)
-
Hydroxycarbamide (hydroxyurea) Informations générales
SectionOther medicines for haemoglobinopathies- Oral > Solid > dosage form: 200 mg; 500 mg; 1 g; 100 mg
-
Methoxy polyethylene glycol-epoetin beta Informations générales
SectionAntianaemia medicinesIndicationsTherapeutic equivalent to erythropoiesis-stimulating agents pour Anaemia due to chronic disease -
Nadroparin Informations générales
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to enoxaparin pour Acute ischaemic heart disease Therapeutic equivalent to enoxaparin pour Venous thromboembolism -
Phytomenadione Informations générales
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 10 mg per mL in ampoule; 1 mg per mL in ampoule
- Oral > Solid: 10 mg tablet
-
Protamine sulfate Informations générales
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 10 mg per mL in 5 mL ampoule
-
Rivaroxaban Informations générales
SectionMedicines affecting coagulationIndicationsTherapeutic equivalent to dabigatran pour Venous thromboembolism Therapeutic equivalent to dabigatran pour Other specified atrial fibrillation -
Tranexamic acid Informations générales
SectionMedicines affecting coagulation- Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule
Indications -
Warfarin Informations générales
SectionMedicines affecting coagulation- Oral > Solid: 5 mg (sodium salt); 1 mg (sodium salt); 2 mg (sodium salt); 0.5 mg (sodium salt)